GlassScriptPhysician profile
Alyssa K Pittman
NPI 1609432855
$2,396.28
in general payments reported to CMS, 2019-2025
14 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $421 · 2024: $303 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,053 · Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,052.79 |
| Food and Beverage | $922.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,578.16 | 2021-2025 | Matrixcombo |
| Lemaitre Vascular, INC. | $116.18 | 2021 | |
| Sirius Medical Systems | $110.00 | 2024 | Pintuition |
| Dilon Technologies, INC. | $105.58 | 2025 | Hemoblast Bellows |
| Myriad Genetic Laboratories, INC. | $104.47 | 2025 | Myrisk |
| Boston Scientific Corporation | $101.32 | 2024 | Spyglass Discover |
| Integra Lifesciences Corporation | $91.99 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stemline Therapeutics INC. | $37.27 | 2025 | Orserdu |
| Astrazeneca Pharmaceuticals LP | $36.47 | 2025 | Imfinzi |
| Merck Sharp & Dohme LLC | $29.43 | 2025 | Lynparza, Keytruda |
| Stryker Corporation | $25.95 | 2025 | Molli, Spy-Phi System |
| Daiichi Sankyo INC. | $21.91 | 2025 | Injectafer |
| Medtronic, INC. | $19.06 | 2025 | Plasmablade(Tm) |
| Sobi, INC | $18.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Pittman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.